Differential Effects of APOE Genotype on MicroRNA Cargo of Cerebrospinal Fluid Extracellular Vesicles in Females With Alzheimer’s Disease Compared to Males
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Multiple biological factors, including age, sex, and genetics, influence Alzheimer’s disease (AD) risk. Of the 6.2 million Americans living with Alzheimer’s dementia in 2021, 3.8 million are women and 2.4 million are men. The strongest genetic risk factor for sporadic AD is apolipoprotein E-e4 (APOE-e4). Female APOE-e4 carriers develop AD more frequently than age-matched males and have more brain atrophy and memory loss. Consequently, biomarkers that are sensitive to biological risk factors may improve AD diagnostics and may provide insight into underlying mechanistic changes that could drive disease progression. Here, we have assessed the effects of sex and APOE-e4 on the miRNA cargo of cerebrospinal fluid (CSF) extracellular vesicles (EVs) in AD. We used ultrafiltration (UF) combined with size exclusion chromatography (SEC) to enrich CSF EVs (e.g., Flotillin+). CSF EVs were isolated from female and male AD or controls (CTLs) that were either APOE-e3,4 or -e3,3 positive (n = 7/group, 56 total). MiRNA expression levels were quantified using a custom TaqMan™ array that assayed 190 miRNAs previously found in CSF, including 25 miRNAs that we previously validated as candidate AD biomarkers. We identified changes in the EV miRNA cargo that were affected by both AD and sex. In total, four miRNAs (miR-16-5p, -331-3p, -409-3p, and -454-3p) were significantly increased in AD vs. CTL, independent of sex and APOE-e4 status. Pathway analysis of the predicted gene targets of these four miRNAs with identified pathways was highly relevant to neurodegeneration (e.g., senescence and autophagy). There were also three miRNAs (miR-146b-5p, -150-5p, and -342-3p) that were significantly increased in females vs. males, independent of disease state and APOE-e4 status. We then performed a statistical analysis to assess the effect of APOE genotype in AD within each sex and found that APOE-e4 status affects different subsets of CSF EV miRNAs in females vs. males. Together, this study demonstrates the complexity of the biological factors associated with AD risk and the impact on EV miRNAs, which may contribute to AD pathophysiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
miRDB: an online database for prediction of functional microRNA targets
Chen, Y., & Wang, X. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkz757 · Cited by 3,277 · cited 4×
“, 2015) and miRDB (Liu and Wang, 2019; Chen and Wang, 2020) to predict targets of the four CSF EV miRNAs significantly associated with AD, as these programs are widely used and frequently updated.”
BackgroundMethodInfluentialReassessment of exosome composition
Jeppesen, D. K., Fenix, A. M., Franklin, J. L., Higginbotham, J. N., Zhang, Q., Zimmerman, L. J., Liebler, D. C., Ping, J., Liu, Q., Evans, R., et al. (2019) · Cell · doi:10.1016/j.cell.2019.02.029 · Cited by 2,975
Shedding microvesicles: artefacts no more
Cocucci, E., Racchetti, G., & Meldolesi, J. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.11.003 · Cited by 1,742
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591 · cited 1×
“In AD, there are disruptions in the endolysosomal pathway within both neurons and glia that affect exosome biogenesis, including RNA and protein cargo (Asai et al., 2015; Goetzl et al., 2016; Mathews and Levy, 2019; Li et al., 2020; Guo et al., 2021).”
BackgroundExtensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study
Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588
EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research
EV-TRACK Consortium, Van Deun, J., Mestdagh, P., Agostinis, P., Akay, Ö., Anand, S., Anckaert, J., Martinez, Z. A., Baetens, T., Beghein, E., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4185 · Cited by 1,284 · cited 1×
“Relevant experimental parameters can be accessed in the EV-TRACK (evtrack.org) knowledgebase (EV-Track et al., 2017).”
BackgroundCogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14103 · Cited by 943 · cited 3×
“Aside from our studies, three (miR-142-3p, -146a-5p, and -146b-5p) of these miRNAs have been identified by others as candidate biomarkers for MCI and/or AD in total CSF (Cogswell et al., 2008; Alexandrov et al., 2012; Kiko et al., 2014; Denk et al., 2015; Nagaraj et al., 2017; Park et al., 2019).”
BackgroundSex modifies the APOE ‐related risk of developing Alzheimer disease
Altmann, A., Tian, L., Henderson, V. W., Greicius, M. D., & Alzheimer's Disease Neuroimaging Initiative Investigators (2014) · Annals of Neurology · doi:10.1002/ana.24135 · Cited by 891 · cited 2×
“In addition, female APOE-e4 carriers are more likely to progress from mild cognitive impairment (MCI) to AD, have more brain atrophy and memory loss, and develop AD more frequently than age-matched males (Fleisher et al., 2008; Altmann et al., 2014; Sampedro et al., 2015).”
BackgroundAstrocyte Senescence as a Component of Alzheimer’s Disease
Bhat, R., Crowe, E. P., Bitto, A., Moh, M., Katsetos, C. D., Garcia, F. U., Johnson, F. B., Trojanowski, J. Q., Sell, C., & Torres, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045069 · Cited by 586 · cited 1×
“In a study using AD brains, immunostaining showed the accumulation of senescent astrocytes (Bhat et al., 2012).”
BackgroundAltered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease
Gui, Y., Liu, H., Zhang, L., Lv, W., & Hu, X. (2015) · Oncotarget · doi:10.18632/oncotarget.6158 · Cited by 552 · cited 13×
“For our study, the average age of AD participants was 73 years old, while the average ages from the other studies were 61 and 63 years old (Gui et al., 2015; McKeever et al., 2018).”
BackgroundMethodResultInfluentialFormation of a protein corona on the surface of extracellular vesicles in blood plasma
Tóth, E. Á., Turiák, L., Visnovitz, T., Cserép, C., Mázló, A., Sódar, B. W., Försönits, A. I., Petővári, G., Sebestyén, A., Komlósi, Z., et al. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12140 · Cited by 522
Reiman, E. M., Arboleda-Velasquez, J. F., Quiroz, Y. T., Huentelman, M. J., Beach, T. G., Caselli, R. J., Chen, Y., Su, Y., Myers, A. J., Hardy, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14279-8 · Cited by 473 · cited 2×
“Importantly, while the APOE-e2 allele is relatively rare and may provide some protection against AD (Reiman et al., 2020), people who inherit one copy of the APOE-e4 allele have an increased chance of developing the disease; those who inherit two copies of the allele are at even greater risk (Sando…”
BackgroundSelf-citationTMEM119 marks a subset of microglia in the human brain
Satoh, J., Kino, Y., Asahina, N., Takitani, M., Miyoshi, J., Ishida, T., & Saito, Y. (2016) · Neuropathology · doi:10.1111/neup.12235 · Cited by 434
Burgos, K., Malenica, I., Metpally, R., Courtright, A., Rakela, B., Beach, T., Shill, H., Adler, C., Sabbagh, M., Villa, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094839 · Cited by 385 · cited 2×
“…μL, and total RNA was isolated using the mirVana™ PARIS™ RNA and a Native Protein Purification Kit (AM1556, Thermo Fisher Scientific), with modification (Burgos et al., 2014), as we have previously reported for CSF and plasma EVs (Lusardi et al., 2017; Wiedrick et al., 2019; Sandau et al., 2020a;…”
MethodZheng, P., Luo, Q., Wang, W., Li, J., Wang, T., Wang, P., Chen, L., Zhang, P., Chen, H., Liu, Y., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0465-5 · Cited by 381
Lipid-based carriers of microRNAs and intercellular communication
Vickers, K. C., & Remaley, A. T. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328350a425 · Cited by 314
Dickens, A. M., Tovar-y-Romo, L. B., Yoo, S.-W., Trout, A. L., Bae, M., Kanmogne, M., Megra, B., Williams, D. W., Witwer, K. W., Gacias, M., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aai7696 · Cited by 285 · cited 4×
“EVs released from CNS cells contribute to cell-tocell communication throughout the CNS and the periphery (Chivet et al., 2012; Dickens et al., 2017; Zhang and Yang, 2018) in normal and pathological processes (Yuyama and Igarashi, 2016; Neven et al.”
BackgroundInfluentialAlzheimer’s disease brain-derived extracellular vesicles spread tau pathology in interneurons
Ruan, Z., Pathak, D., Venkatesan Kalavai, S., Yoshii-Kitahara, A., Muraoka, S., Bhatt, N., Takamatsu-Yukawa, K., Hu, J., Wang, Y., Hersh, S., et al. (2021) · Brain · doi:10.1093/brain/awaa376 · Cited by 283
Sando, S. B., Melquist, S., Cannon, A., Hutton, M. L., Sletvold, O., Saltvedt, I., White, L. R., Lydersen, S., & Aasly, J. O. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-9 · Cited by 261 · cited 2×
“, 2020), people who inherit one copy of the APOE-e4 allele have an increased chance of developing the disease; those who inherit two copies of the allele are at even greater risk (Sando et al., 2008; Reiman et al., 2020).”
BackgroundCellular senescence and Alzheimer disease: the egg and the chicken scenario
Saez-Atienzar, S., & Masliah, E. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0325-z · Cited by 257 · cited 1×
“Of these, 10 of the top 17 pathways are known to be relevant to AD, including the top three overall pathways: senescence, TGF-β signaling, and epithelial adherens junction signaling (Figure 7G) (Caraci et al., 2018; Pearson et al., 2020; Saez-Atienzar and Masliah, 2020).”
BackgroundMicroRNAs in Plasma and Cerebrospinal Fluid as Potential Markers for Alzheimer's Disease
Kiko, T., Nakagawa, K., Tsuduki, T., Furukawa, K., Arai, H., & Miyazawa, T. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-130932 · Cited by 256
MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease
Denk, J., Boelmans, K., Siegismund, C., Lassner, D., Arlt, S., & Jahn, H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126423 · Cited by 236 · cited 3×
“Aside from our studies, three (miR-142-3p, -146a-5p, and -146b-5p) of these miRNAs have been identified by others as candidate biomarkers for MCI and/or AD in total CSF (Cogswell et al., 2008; Alexandrov et al., 2012; Kiko et al., 2014; Denk et al., 2015; Nagaraj et al., 2017; Park et al., 2019).”
BackgroundMaddalena, A., Papassotiropoulos, A., Müller-Tillmanns, B., Jung, H. H., Hegi, T., Nitsch, R. M., & Hock, C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.9.1202 · Cited by 204 · cited 2×
“We further showed that while the ratio of CSF Aβ42:total-Tau (clinical markers for AD diagnosis (Maddalena et al., 2003)) predicted MCI with AUC of 0.”
BackgroundInfluentialAstrocyte senescence promotes glutamate toxicity in cortical neurons
Limbad, C., Oron, T. R., Alimirah, F., Davalos, A. R., Tracy, T. E., Gan, L., Desprez, P.-Y., & Campisi, J. (2020) · PLOS ONE · doi:10.1371/journal.pone.0227887 · Cited by 183
You, Y., Borgmann, K., Edara, V. V., Stacy, S., Ghorpade, A., & Ikezu, T. (2020) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2019.1706801 · Cited by 176 · cited 1×
“The increased yield is a key factor considering the low amount of EVs in CSF, given that the total protein content of CSF is 50–100 times lower than plasma (Yuan and Desiderio, 2005).”
BackgroundCaraci, F., Spampinato, S. F., Morgese, M. G., Tascedda, F., Salluzzo, M. G., Giambirtone, M. C., Caruso, G., Munafò, A., Torrisi, S. A., Leggio, G. M., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.007 · Cited by 172 · cited 1×
“Of these, 10 of the top 17 pathways are known to be relevant to AD, including the top three overall pathways: senescence, TGF-β signaling, and epithelial adherens junction signaling (Figure 7G) (Caraci et al., 2018; Pearson et al., 2020; Saez-Atienzar and Masliah, 2020).”
BackgroundColacurcio, D. J., Pensalfini, A., Jiang, Y., & Nixon, R. A. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.001 · Cited by 167
Astrocytic ApoE reprograms neuronal cholesterol metabolism and histone-acetylation-mediated memory
Li, X., Zhang, J., Li, D., He, C., He, K., Xue, T., Wan, L., Zhang, C., & Liu, Q. (2021) · Neuron · doi:10.1016/j.neuron.2021.01.005 · Cited by 165 · cited 1×
“In AD, there are disruptions in the endolysosomal pathway within both neurons and glia that affect exosome biogenesis, including RNA and protein cargo (Asai et al., 2015; Goetzl et al., 2016; Mathews and Levy, 2019; Li et al., 2020; Guo et al., 2021).”
BackgroundRiancho, J., Vázquez-Higuera, J. L., Pozueta, A., Lage, C., Kazimierczak, M., Bravo, M., Calero, M., Gonalezález, A., Rodríguez, E., Lleó, A., et al. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161179 · Cited by 159
APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls
Sampedro, F., Initiative, F. T. A. D. N., Vilaplana, E., de Leon, M. J., Alcolea, D., Pegueroles, J., Montal, V., Carmona-Iragui, M., Sala, I., Sánchez-Saudinos, M.-B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5185 · Cited by 135
Sathe, G., Na, C. H., Renuse, S., Madugundu, A. K., Albert, M., Moghekar, A., & Pandey, A. (2019) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201800105 · Cited by 126
A combined miRNA-piRNA signature to detect Alzheimer’s disease
Jain, G., Stuendl, A., Rao, P., Berulava, T., Pena Centeno, T., Kaurani, L., Burkhardt, S., Delalle, I., Kornhuber, J., Hüll, M., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0579-2 · Cited by 121 · cited 5×
“…of CSF EVs in AD used precipitation, ultracentrifugation, or density gradient ultracentrifugation-based methods to fractionate CSF (Liu et al., 2014; Gui et al., 2015; Riancho et al., 2017; McKeever et al., 2018; Schneider et al., 2018; Jain et al., 2019; Kumar and Reddy, 2021; Tan et al., 2021).”
BackgroundMethodInfluentialApolipoprotein E4 genotype compromises brain exosome production
Peng, K. Y., Pérez-González, R., Alldred, M. J., Goulbourne, C. N., Morales-Corraliza, J., Saito, M., Saito, M., Ginsberg, S. D., Mathews, P. M., & Levy, E. (2019) · Brain · doi:10.1093/brain/awy289 · Cited by 109
Díaz González, M., Buberman, A., Morales, M., Ferrer, I., & Knafo, S. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.683290 · Cited by 12 · cited 1×
“A prominent AD-related protein in the autophagy pathway is PTEN (Diaz Gonzalez et al., 2021), which we identified as a potential gene target of miR-454-3p (Supplementary Tables S4, S5).”
Background
Cited by
Unveiling the Complex Role of Exosomes in Alzheimer’s Disease
Sun, M., & Chen, Z. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s466821 · Cited by 39
“[213]”
Proteomic Profiling of Plasma- and Gut-Derived Extracellular Vesicles in Obesity
Baptista Pereira, P., Torrejón, E., Ferreira, I., Carvalho, A. S., Teshima, A., Sousa-Lima, I., Beck, H. C., Costa-Silva, B., Matthiesen, R., Macedo, M. P., et al. (2024) · Nutrients · doi:10.3390/nu16050736 · Cited by 6
Metadata
- Authors
- Sandau, U. S., McFarland, T. J., Smith, S. J., Galasko, D. R., Quinn, J. F., & Saugstad, J. A.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2022-04-27
- Volume
- 10
- Pages
- 864022-864022
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W4285741865
- Cited by
- 42
- References
- 34
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.